India has achieved a remarkable 21% drop in TB cases, yet still represents a quarter of global infections. Intensified national efforts have signific ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...
UST, a leading AI and digital transformation solutions company, has launched a six-month programme to provide nutritious food kits to tuberculosis (TB) patients in Thiruvananthapuram and Ernakulam ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...
Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium ...
Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...
A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment ...